Buy DiaMedica Therapeutics Inc Stock | DMAC Stock Price & Latest News | Public
DMAC

DiaMedica Therapeutics Inc

$0.00 (0.00%)Today
    Small Market Cap

    About DMAC

    DiaMedica Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of novel recombinant proteins. It offers DM199 product which focuses on acute ischemic stroke (AIS) and chronic kidney disease (CKD). The company was founded by ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.06
    -0.13
    -0.19
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.19

    Actual EPS
    Q4 2020

    Stats

    Market Cap$80,76M
    Volume2,17k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$8.80
    1 Year Low$1.87
    Open$4.27
    High$4.60
    Low$4.27

    Buy any stock with any amount of money.

    Download the App
    Download the app